Valuation : Medpace Holdings, Inc.

Market Cap 16.58B 14.27B 13.4B 12.24B 22.98B 1,578B 23.15B 159B 61.8B 800B 62.25B 60.9B 2,649B P/E 2026 *
33.8x
P/E 2027 * 31x
Enterprise Value 15.78B 13.58B 12.75B 11.64B 21.87B 1,501B 22.03B 151B 58.81B 761B 59.24B 57.95B 2,520B EV / Sales 2026 *
5.53x
EV / Sales 2027 * 5.06x
Free-Float
80.32%
Yield 2026 *
-
Yield 2027 * -
1 day-1.11%
1 week-4.20%
Current month+2.92%
1 month+2.92%
3 months+31.57%
6 months+27.64%
Current year+5.76%
1 week 583.16
Extreme 583.1575
625.44
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/26/26 A Exercice

Director

11,574 0.0415%
8/26/26 A Sell

Chief Executive Officer

-4,000 0.0143%
8/24/26 A Sell

Chief Executive Officer

-1,983 0.0071%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-4.20%+25.49%+119.78% 16.58B
-0.38%-2.59%+0.28%+17.12% 49.81B
-1.11%-2.84%+420.04%+505.15% 44.06B
-0.21%+0.37%+36.88%+17.32% 42.99B
-1.95%-3.33%+8.29%+73.25% 40.88B
-0.94%-1.77%+18.34%+46.84% 33.11B
+6.10%+4.40% - - 17.27B
-0.22%-2.29%+11.39%+27.79% 14.63B
-1.12%-3.46%+76.50%+39.37% 13.76B
-2.96%-4.89%-7.23%-36.53% 12.73B
Average -0.40%-1.72%+65.55%+90.01% 28.58B
Weighted average by Cap. -0.57%-1.65%+84.17%+114.95%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.31B 2.1B 3.95B 271B 3.98B 27.32B 10.63B 138B 10.71B 10.47B 456B 3.03B 2.61B 2.45B 2.23B 4.2B 288B 4.23B 29B 11.28B 146B 11.37B 11.12B 484B
Net income 503M 433M 406M 371M 697M 47.82B 702M 4.81B 1.87B 24.25B 1.89B 1.85B 80.29B 547M 471M 442M 403M 758M 52.01B 763M 5.24B 2.04B 26.37B 2.05B 2.01B 87.32B
Net Debt -802M -691M -649M -592M -1.11B -76.34B -1.12B -7.69B -2.99B -38.71B -3.01B -2.95B -128B -1.25B -1.08B -1.01B -924M -1.74B -119B -1.75B -12B -4.67B -60.42B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
31/08/26 $593.99 -1.11% 347,286
28/08/26 $600.65 -1.79% 186,917
27/08/26 $611.57 -1.21% 198,155
26/08/26 $619.05 +0.81% 149,419
25/08/26 $614.06 -0.96% 247,113
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
593.99USD
Average target price
581.83USD
Spread / Average Target
-2.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock